Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: A clinical, pathological, and genetic study

Human Pathology

Volumn 46, Issue 11, 2015, Pages 1769-1775

  Yeh, Matthew M ^a   Liu, Yajuan ^a   Torbenson, Michael ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Hepatocellular carcinoma; Metabolic syndrome; Steatohepatitic; Steatohepatitis; Steatosis

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CANCER GENETICS; CHROMOSOME 7; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; FOLLOW UP; GENOMICS; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER METABOLISM; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; STEATOHEPATITIC HEPATOCELLULAR CARCINOMA; TISSUE REACTION; VERY ELDERLY; COMPLICATION; GENETICS; LIVER; LIVER TUMOR; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PATHOLOGY; RISK FACTOR;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHROMOSOME ABERRATIONS; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTORS;

EID: 84945302719     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.07.018     Document Type: Article

References (36)

1. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
2. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
3. H. Nordenstedt, D.L. White, and H.B. El-Serag The changing pattern of epidemiology in hepatocellular carcinoma Dig Liver Dis 42 Suppl 3 2010 S206 S214
4. B.Q. Starley, C.J. Calcagno, and S.A. Harrison Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology 51 2010 1820 1832
5. G. Baffy, E.M. Brunt, and S.H. Caldwell Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace J Hepatol 56 2012 1384 1391
6. J.M. Regimbeau, M. Colombat, P. Mognol, and et al. Obesity and diabetes as a risk factor for hepatocellular carcinoma Liver Transpl 10 2004 S69 S73
7. V. Donadon, M. Balbi, M. Ghersetti, and et al. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease World J Gastroenterol 15 2009 2506 2511
8. J.A. Davila, R.O. Morgan, Y. Shaib, K.A. McGlynn, and H.B. El-Serag Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study Gut 54 2005 533 539
9. H.B. El-Serag, P.A. Richardson, and J.E. Everhart The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans Am J Gastroenterol 96 2001 2462 2467
10. J. Polesel, A. Zucchetto, M. Montella, and et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma Ann Oncol 20 2009 353 357
11. C. Gao, and S.K. Yao Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma? Hepatobiliary Pancreat Dis Int 8 2009 465 473
12. H.B. El-Serag, H. Hampel, and F. Javadi The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence Clin Gastroenterol Hepatol 4 2006 369 380
13. S.W. Lai, P.C. Chen, K.F. Liao, C.H. Muo, C.C. Lin, and F.C. Sung Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study Am J Gastroenterol 107 2012 46 52
14. H.O. Adami, W.H. Chow, O. Nyren, and et al. Excess risk of primary liver cancer in patients with diabetes mellitus J Natl Cancer Inst 88 1996 1472 1477
15. H. Verbaan, G. Hoffmann, S. Lindgren, S. Nilsson, A. Widell, and S. Eriksson Long-term outcome of chronic hepatitis C infection in a low-prevalence area Scand J Gastroenterol 33 1998 650 655
16. D.H. Lawson, J.M. Gray, C. McKillop, J. Clarke, F.D. Lee, and R.S. Patrick Diabetes mellitus and primary hepatocellular carcinoma Q J Med 61 1986 945 955
17. T.M. Welzel, B.I. Graubard, S. Zeuzem, H.B. El-Serag, J.A. Davila, and K.A. McGlynn Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database Hepatology 54 2011 463 471
18. C. Leung, S.W. Yeoh, D. Patrick, and et al. Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease World J Gastroenterol 21 2015 1189 1196
19. J. Alexander, M. Torbenson, T.-T. Wu, and M.M. Yeh Nonalcoholic fatty liver disease contributes to hepatocellular carcinoma in non-cirrhotic liver: a clinical and pathological study J Gastroenterol Hepatol 28 2013 848 854
20. L.A. Adams, J.F. Lymp, J. St Sauver, and et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121
21. D.L. White, F. Kanwal, and H.B. El-Serag Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review Clin Gastroenterol Hepatol 10 2012 1342 1359
22. M. Salomao, W.M. Yu, R.S. Brown Jr., J.C. Emond, and J.H. Lefkowitch Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH Am J Surg Pathol 34 2010 1630 1636
23. M. Salomao, H. Remotti, R. Vaughan, A.B. Siegel, J.H. Lefkowitch, and R.K. Moreira The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis Hum Pathol 43 2012 737 746
24. F.T. Bosman, F. Carneiro, R. Rhuban, and et al. WHO classification of tumours of the digestive system 2010 IARC Lyon
25. D. Jain, N.C. Nayak, V. Kumaran, and S. Saigal Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India Arch Pathol Lab Med 137 2013 961 966
26. J. Shibahara, S. Ando, Y. Sakomoto, N. Kokudo, and M. Fukayama Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients Histopathology 64 2014 951 962
27. S.P. Cleary, W.R. Jeck, X. Zhao, and et al. Identification of driver genes in hepatocellular carcinoma by exome sequencing Hepatology 58 2013 1693 1702
28. Z. Kan, H. Zheng, X. Liu, and et al. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma Genome Res 23 2013 1422 1433
29. A. Fujimoto, Y. Totoki, T. Abe, and et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators Nat Genet 44 2012 760 764
30. S.M. Zain, R. Mohamed, D.N. Cooper, and et al. Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non-alcoholic fatty liver disease PLoS One 9 2014 e95604
31. M.M. Yeh, R.S. Yeung, S. Apisarnthanarax, and et al. Multidisciplinary perspective of hepatocellular carcinoma: a Pacific Northwest experience World J Hepatol 7 2015 1460 1483 [doi: 10.4254]
32. J.N. Honeyman, E.P. Simon, N. Robine, and et al. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma Science 343 2014 1010 1014
33. K.J. Riehle, M.M. Yeh, J.J. Yu, and et al. mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma Mod Pathol 28 2015 103 110
34. X.Y. Guan, Y. Fang, J.S. Sham, and et al. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization Genes Chromosomes Cancer 29 2000 110 116
35. P.E. Zondervan, J. Wink, J.C. Alers, and et al. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias J Pathol 192 2000 207 215
36. P. Moinzadeh, K. Breuhahn, H. Stutzer, and P. Schirmacher Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade - results of an explorative CGH meta-analysis Br J Cancer 92 2005 935 941